Skip to content

Depression: all studies

Page 566 of 1,034: studies 5,651 to 5,660 of 10,336, newest first. Back to the depression overview

Research

A scoping review on mindfulness-based interventions for families of patients with advanced cancer.

GHM open June 30, 2025 Junko Morishita, Yuka Takita

We aimed to conduct a scoping review to investigate mindfulness-based interventions targeting the families of patients with advanced cancer to elucidate the characteristics of the target population, program content, and evaluation methods. The review followed the Joanna Briggs Institute guidelines, and relevant studies were identified through searches in the PubMed, CINAHL, and Cochrane...

Utilization of Breathwork Meditation in Improving Wellness in Trainees of Speech-Language Pathology: A Prospective Cohort Study

Perspectives of the ASHA Special Interest Groups June 30, 2025 Ting‐fen Lin, Leila Mori, Akansha Batra et al. 1 citation

Purpose: Stress is common in speech-language pathology. While sources of stress cannot be eliminated overnight, lifestyle changes such as learning tools to be resilient can be implemented. Therefore, this study aimed to assess the impact of an evidence-based breathwork meditation program (Sudarshan Kriya Yoga Breath Meditation [SKY]) on the well-being of trainees in speech-language pathology....

DOI: 10.1044/2025_persp-24-00099 (opens in new tab) Meditation Speech-language pathology Prospective cohort study Audiology +1

The role of modern neuroscience in the renaissance of psychedelic research

Revista Costarricense de Psicología June 30, 2025 Kathryn E. Evans, Crystian I Massengill, Jonnathan Singh Alvarado

The primary objective of this review is to highlight the increasing relevance of experimental neuroscience in advancing the mechanistic understanding and translational potential of classic psychedelics and other psychoactive substances of interest. First, we review clinical evidence for the therapeutic potential of psychedelics in the context of depression, anxiety, and addiction. Second,we...

DOI: 10.22544/rcps.v44i01.10 (opens in new tab) The renaissance Cognitive science Art history

Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment

Medical Science Monitor June 30, 2025 Andrzej Silczuk, Robert Madejek, Tytus Koweszko et al. 4 citations

Psychedelics, derived from the Greek words "psyche" (soul) and "deloun" (revealing), are substances historically and currently considered "soul-revealing". Also termed hallucinogens due to their impact on sensory perception, they are further categorized into hallucinogens, such as lysergic acid diethylamide (LSD), psilocybin, and mescaline; entactogens or empathogens, such as...

DOI: 10.12659/msm.948302 (opens in new tab) Mental health Medline Psychotherapist Intensive care medicine

Ketamine in clinical practice: transitioning from anesthetic agent to psychiatric therapeutic.

CNS Spectrums June 30, 2025 Jose-Manuel Quintero, Rosa-Helena Bustos, Sharon Lechtig-Wassermann et al. 6 citations

Ketamine, originally synthesized in 1962, has gained increasing attention due to its rapid and sustained antidepressant effects in treatment-resistant depression (TRD). Unlike traditional antidepressants, ketamine acts on multiple neurotransmitter systems, including NMDA receptor antagonism and AMPA receptor potentiation, offering a novel mechanism for mood regulation. Beyond psychiatry,...

DOI: 10.1017/S1092852925100333 (opens in new tab) Full text (opens in new tab) Ketamine Anesthetic Recreational drug Antidepressant therapy +2

Veterans' engagement in mindfulness practices following intervention.

Psychological Services June 30, 2025 Tracy Herrmann, Amir Ramezani, Ryan Lackner et al.

Mindfulness-based interventions are complementary and integrative health interventions, widely used for mental health. However, while these interventions show significant benefits for veterans, veterans are more likely to drop out of mindfulness-based interventions than other treatments. This study aimed to evaluate veterans' motivations for and long-term engagement in mindfulness practices...

DOI: 10.1037/ser0000950 (opens in new tab) Full text (opens in new tab) Mindfulness. Meditation. Mindful practice. Awareness training. +22

Psychedelic Trips: Travel Within the United States to Use Psychedelic Drugs After Legalization.

Annals of emergency medicine June 30, 2025 Joshua C. Black, Karilynn M Rockhill, Evelyn J Fox et al. 4 citations

Oregon and Colorado have legalized possession of natural psychedelic drugs. We assessed if travel to use psychedelics in decriminalized states is occurring and compared the use patterns of travelers with nontravelers. The National Survey Investigating Hallucinogen Trends is a cross-sectional behavioral survey fielded from April to June 2024 to every US state. The survey asks whether individuals...

DOI: 10.1016/j.annemergmed.2025.05.016 (opens in new tab) Full text (opens in new tab) Drug tourism Health policy National survey Cross-state travel +9

Revisiting the Unusual: Investigating the Prevalence and Validity of Nonordinary Experiences as a Window into Consciousness

Research Square June 29, 2025 Ronald Fischer, Giovanna Bortolini, Tiago Bortolini et al. preprint

Abstract Consciousness research has largely overlooked systematic examination of nonordinary experiences (NOEs) in the general population. Such experiences are subjectively marked as unusual or special compared to mundane ones, are challenging to quantify and disciplinary biases complicate accurate assessments of population-wide prevalence rates. Using descriptive, non-judgmental phrasing of...

Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics

Psychoactives June 29, 2025 Mathieu Fradet

Psychedelic treatments are emerging as promising interventions for many mental health conditions. These interventions are not offered in a standardized fashion across studies and between different healthcare centers. Beyond differences in substances and doses, there is also a great heterogeneity in the interventions provided by therapists. The current review offers a summary of important...

DOI: 10.3390/psychoactives4030021 (opens in new tab) Psychotherapist Psychological intervention Rigour Psychoanalysis +1

Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease

Global Journal of Medical Research June 28, 2025 Norman W. Barton

Parkinson’s Disease (PD) is a progressive neurodegenerative disorder marked by motor symptoms due to dopaminergic degeneration and non-motor symptoms such as depression, anxiety, and cognitive impairment, which significantly affect patients' quality of life. Traditional dopaminergic therapies address motor symptoms but offer limited efficacy for neuropsychiatric manifestations. Psilocybin, a...